Patents by Inventor Min Son KWEON

Min Son KWEON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240016876
    Abstract: The present invention relates to a composition for hangover relief, comprising a noni fruit extract or a fraction thereof, and more specifically provides a noni fruit extract or a fraction thereof, which is prepared using a certain concentration of ethanol as an extraction solvent, to contain a large amount of polysaccharides having excellent hangover relieving functionality and an average molecular weight of 8 kDa to 10 kDa.
    Type: Application
    Filed: November 17, 2021
    Publication date: January 18, 2024
    Applicants: Cosmax NBT, Inc., Cosmax NS, Inc.
    Inventors: Ji Hwan JANG, Min Son KWEON, Su Young CHOI
  • Publication number: 20230110749
    Abstract: The present invention relates to a functional food composition for enhancing muscular function and exercise performance and a method for preparing same. According to the present invention, provided is a composition which enables increased generation of factors associated with myogenesis and energy metabolism and thus enhances exercise performance and muscular function. More particularly, mitochondria and muscle cell synthesis is increased and muscular atrophy is inhibited, and thus muscle exercise effects can be increased and fatigue is reduced. The composition can be applied as a health function composition to various fields such as foods.
    Type: Application
    Filed: August 11, 2022
    Publication date: April 13, 2023
    Inventors: Jin Hak KIM, Ji Hwan JANG, Jeong Ho GEUM, Min Son KWEON, Su Young CHOI, Sang Woo KIM, Jae Kwan HWANG
  • Publication number: 20210401916
    Abstract: The present invention relates to a composition for preventing or treating a muscle disorder, which includes a Chrysanthemum extract or 3,5-dicaffeoylquinic acid as an active ingredient, and specifically, it may be used to reduce mRNA expression of atrogin-1 and MuRF1, which are main biomarkers involved in muscle protein degradation and increase mRNA expression of the mTOR protein, which is a main biomarker involved in muscle protein formation, and myogenin and MyoD, which are biomarkers related to muscle differentiation, thereby reducing muscle loss, and thus the Chrysanthemum extract or 3,5-dicaffeoylquinic acid can be used in prevention and treatment of a muscle disorder, or improvement in muscle function. In addition, the Chrysanthemum extract or 3,5-dicaffeoylquinic acid increases the activity of SIRT1 and PGC-1?, which are the main biomarkers involved in exercise performance, thereby excellently enhancing exercise performance.
    Type: Application
    Filed: September 20, 2021
    Publication date: December 30, 2021
    Applicants: Industry-Academic Cooperation Foundation, Yonsei University, Cosmax NBT, Inc., Cosmax NS, Inc.
    Inventors: Jae Kwan HWANG, Jun Gon YUN, Mi Bo KIM, Chang Hee KIM, Joon Hyung LEE, Do Wan KWON, Su Young CHOI, Jin Hak KIM, Ji Hwan JANG, Jeong Ho GEUM, Min Son KWEON
  • Patent number: 11160840
    Abstract: The present invention relates to a composition for preventing or treating a muscle disorder, which includes a chrysanthemum extract or 3,5-dicaffeoylquinic acid as an active ingredient, and specifically, it may be used to reduce mRNA expression of atrogin-1 and MuRF1, which are main biomarkers involved in muscle protein degradation and increase mRNA expression of the mTOR protein, which is a main biomarker involved in muscle protein formation, and myogenin and MyoD, which are biomarkers related to muscle differentiation, thereby reducing muscle loss, and thus the chrysanthemum extract or 3,5-dicaffeoylquinic acid can be used in prevention and treatment of a muscle disorder, or improvement in muscle function. In addition, the chrysanthemum extract or 3,5-dicaffeoylquinic acid increases the activity of SIRT1 and PGC-1?, which are the main biomarkers involved in exercise performance, thereby excellently enhancing exercise performance.
    Type: Grant
    Filed: November 30, 2017
    Date of Patent: November 2, 2021
    Assignees: Industry-Academic Cooperation Foundation, Yonsei University, Cosmax NBT, Inc., Cosmax NS, Inc.
    Inventors: Jae Kwan Hwang, Jun Gon Yun, Mi Bo Kim, Chang Hee Kim, Joon Hyung Lee, Do Wan Kwon, Su Young Choi, Jin Hak Kim, Ji Hwan Jang, Jeong Ho Geum, Min Son Kweon
  • Publication number: 20210145911
    Abstract: The present invention relates to a functional food composition for enhancing muscular function and exercise performance and a method for preparing same. According to the present invention, provided is a composition which enables increased generation of factors associated with myogenesis and energy metabolism and thus enhances exercise performance and muscular function. More particularly, mitochondria and muscle cell synthesis is increased and muscular atrophy is inhibited, and thus muscle exercise effects can be increased and fatigue is reduced. The composition can be applied as a health function composition to various fields such as foods.
    Type: Application
    Filed: March 8, 2019
    Publication date: May 20, 2021
    Inventors: Jin Hak KIM, Ji Hwan JANG, Jeong Ho GEUM, Min Son KWEON, Su Young CHOI, Sang Woo KIM, Jae Kwan HWANG
  • Publication number: 20200009208
    Abstract: The present invention relates to a composition for preventing or treating a muscle disorder, which includes a chrysanthemum extract or 3,5-dicaffeoylquinic acid as an active ingredient, and specifically, it may be used to reduce mRNA expression of atrogin-1 and MuRF1, which are main biomarkers involved in muscle protein degradation and increase mRNA expression of the mTOR protein, which is a main biomarker involved in muscle protein formation, and myogenin and MyoD, which are biomarkers related to muscle differentiation, thereby reducing muscle loss, and thus the chrysanthemum extract or 3,5-dicaffeoylquinic acid can be used in prevention and treatment of a muscle disorder, or improvement in muscle function. In addition, the chrysanthemum extract or 3,5-dicaffeoylquinic acid increases the activity of SIRT1 and PGC-1?, which are the main biomarkers involved in exercise performance, thereby excellently enhancing exercise performance.
    Type: Application
    Filed: November 30, 2017
    Publication date: January 9, 2020
    Applicants: Industry-Academic Cooperation Foundation, Yonsei University, Cosmax NBT, Inc., Cosmax NS, Inc.
    Inventors: Jae Kwan HWANG, Jun Gon YUN, Mi Bo KIM, Chang Hee KIM, Joon Hyung LEE, Do Wan KWON, Su Young CHOI, Jin Hak KIM, Ji Hwan JANG, Jeong Ho GEUM, Min Son KWEON